Ubrelvy 100 MG tablet UD 10S
Ended Awarded Last action
- Contract number
- SPE2DR26FU794
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $22,287
Award facts
- Contract value 100% obligated
- $22,286.82 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $22,286.82 to AmerisourceBergen Drug Corp for UBRELVY 100 mg tablets (10-count unit dose packaging) on December 16, 2025, with completion scheduled for December 17, 2025. This firm fixed-price, non-set-aside contract is part of AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The pharmaceutical distributor, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location.
UBRELVY (ubrogepant) is a calcitonin gene-related peptide (CGRP) antagonist indicated for acute migraine treatment, reflecting the federal healthcare system's need for specialty medications to support military and veteran populations. As a major pharmaceutical supplier to the Defense Health Agency and related federal healthcare systems, AmerisourceBergen maintains extensive capabilities in delivering both brand-name and generic medications, vaccines, and medical supplies across multiple therapeutic domains through its competitive DLA prime vendor relationship. This delivery order represents one transaction within the company's comprehensive pharmaceutical support vehicle serving global military healthcare programs.
Quick answers
Who was awarded contract SPE2DR26FU794?
SPE2DR26FU794 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 16, 2025.
How much is contract SPE2DR26FU794 worth?
The government has obligated $22,287 on SPE2DR26FU794.
Is contract SPE2DR26FU794 an order under another contract?
Yes. SPE2DR26FU794 is a delivery order under SPE2DR25D1053, an indefinite delivery contract.
Was contract SPE2DR26FU794 competed?
The extent of competition for SPE2DR26FU794 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award